{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:42:18Z","timestamp":1760708538523,"version":"build-2065373602"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Neurobiology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.conb.2021.08.003","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T08:07:49Z","timestamp":1632470869000},"page":"48-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["On the cusp of cures: Breakthroughs in Batten disease research"],"prefix":"10.1016","volume":"72","author":[{"given":"Jon J.","family":"Brudvig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2504-4942","authenticated-orcid":false,"given":"Jill M.","family":"Weimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.conb.2021.08.003_bib1","article-title":"Transmembrane Batten disease proteins interact with a shared network of vesicle sorting proteins to regulate synaptic composition and function","author":"Rechtzigel","year":"2021","journal-title":"BioRxiv"},{"key":"10.1016\/j.conb.2021.08.003_bib2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3389\/fnmol.2017.00266","article-title":"The networks of genes encoding palmitoylated proteins in axonal and synaptic compartments are affected in PPT1 overexpressing neuronal-like cells","volume":"10","author":"Pezzini","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.conb.2021.08.003_bib3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fncel.2019.00092","article-title":"The interactome of palmitoyl-protein thioesterase 1 (PPT1) affects neuronal morphology and function","volume":"13","author":"Sapir","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.conb.2021.08.003_bib4","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41556-018-0228-7","article-title":"CLN8 is an endoplasmic reticulum cargo receptor that regulates lysosome biogenesis","volume":"20","author":"di Ronza","year":"2018","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.conb.2021.08.003_bib5","first-page":"4118","article-title":"A\u00a0CLN6-CLN8 complex recruits lysosomal enzymes at the ER for Golgi transfer","volume":"130","author":"Bajaj","year":"2020","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.conb.2021.08.003_bib6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41586-020-1968-7","article-title":"ATP13A2 deficiency disrupts lysosomal polyamine export","volume":"578","author":"van Veen","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.conb.2021.08.003_bib7","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jmb.2019.01.027","article-title":"Progranulin stimulates the in\u00a0vitro maturation of pro-cathepsin D at acidic pH","volume":"431","author":"Butler","year":"2019","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.conb.2021.08.003_bib8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00401-017-1719-5","article-title":"Regulation of cathepsin D activity by the FTLD protein progranulin","volume":"134","author":"Zhou","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.conb.2021.08.003_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.gendis.2017.05.001","article-title":"Progranulin acts as a shared chaperone and regulates multiple lysosomal enzymes","volume":"4","author":"Jian","year":"2017","journal-title":"Genes Dis"},{"key":"10.1016\/j.conb.2021.08.003_bib10","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/jimd.12106","article-title":"Cln3-mutations underlying juvenile neuronal ceroid lipofuscinosis cause significantly reduced levels of Palmitoyl-protein thioesterases-1 (Ppt1)-protein and Ppt1-enzyme activity in the lysosome","volume":"42","author":"Appu","year":"2019","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.conb.2021.08.003_bib11","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.234047","article-title":"CLN3 regulates endosomal function by modulating Rab7A-effector interactions","volume":"133","author":"Yasa","year":"2020","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.conb.2021.08.003_bib12","doi-asserted-by":"crossref","first-page":"9592","DOI":"10.1074\/jbc.RA119.008852","article-title":"Lysosomal proteome analysis reveals that CLN3-defective cells have multiple enzyme deficiencies associated with changes in intracellular trafficking","volume":"294","author":"Schmidtke","year":"2019","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.conb.2021.08.003_bib13","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1042\/BCJ20210171","article-title":"CLN5 and CLN3 function as a complex to regulate endolysosome fusion","volume":"478","author":"Yasa","year":"2021","journal-title":"Biochem J"},{"key":"10.1016\/j.conb.2021.08.003_bib14","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.28685","article-title":"Defective synaptic transmission causes disease signs in a mouse model of juvenile neuronal ceroid lipofuscinosis","volume":"6","author":"Gr\u00fcnewald","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.conb.2021.08.003_bib15","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131961","article-title":"Neuronal network dysfunction precedes storage and neurodegeneration in a lysosomal storage disorder","volume":"4","author":"Ahrens-Nicklas","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.conb.2021.08.003_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.nbd.2016.12.022","article-title":"Age-dependent alterations in neuronal activity in the hippocampus and visual cortex in a mouse model of Juvenile Neuronal Ceroid Lipofuscinosis (CLN3)","volume":"100","author":"Burkovetskaya","year":"2017","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.conb.2021.08.003_bib17","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/jimd.12242","article-title":"Cln1-mutations suppress Rab7-RILP interaction and impair autophagy contributing to neuropathology in a mouse model of infantile neuronal ceroid lipofuscinosis","volume":"43","author":"Sarkar","year":"2020","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.conb.2021.08.003_bib18","doi-asserted-by":"crossref","first-page":"569598","DOI":"10.3389\/fncel.2020.569598","article-title":"Electrophysiological profile remodeling via selective suppression of voltage-gated currents by CLN1\/PPT1 overexpression in human neuronal-like cells","volume":"14","author":"Demontis","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.conb.2021.08.003_bib19","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.40316","article-title":"Developmental NMDA receptor dysregulation in the infantile neuronal ceroid lipofuscinosis mouse model","volume":"8","author":"Koster","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.conb.2021.08.003_bib20","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1016\/j.celrep.2019.08.035","article-title":"A\u00a0high-content screen identifies TPP1 and aurora B as regulators of axonal mitochondrial transport","volume":"28","author":"Shlevkov","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.conb.2021.08.003_bib21","doi-asserted-by":"crossref","first-page":"8000","DOI":"10.1073\/pnas.1817183116","article-title":"Loss of postnatal quiescence of neural stem cells through mTOR activation upon genetic removal of cysteine string protein-\u03b1","volume":"116","author":"Nieto-Gonz\u00e1lez","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.conb.2021.08.003_bib22","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00401-015-1512-2","article-title":"Neuronal ceroid lipofuscinosis with DNAJC5\/CSP\u03b1 mutation has PPT1 pathology and exhibit aberrant protein palmitoylation","volume":"131","author":"Henderson","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.conb.2021.08.003_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41421-018-0012-7","article-title":"DNAJC5 facilitates USP19-dependent unconventional secretion of misfolded cytosolic proteins","volume":"4","author":"Xu","year":"2018","journal-title":"Cell Discov"},{"key":"10.1016\/j.conb.2021.08.003_bib24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41598-018-36379-z","article-title":"Autophagy-lysosome pathway alterations and alpha-synuclein up-regulation in the subtype of neuronal ceroid lipofuscinosis, CLN5 disease","volume":"9","author":"Adams","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.conb.2021.08.003_bib25","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1093\/hmg\/ddz165","article-title":"Loss of Cln5 leads to altered Gad1 expression and deficits in interneuron development in mice","volume":"28","author":"Singh","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.conb.2021.08.003_bib26","first-page":"1089","article-title":"Loss of Cln5 causes altered neurogenesis in a mouse model of a childhood neurodegenerative disorder","volume":"10","author":"Savchenko","year":"2017","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.conb.2021.08.003_bib27","article-title":"A CLN6-CRMP2-KLC4 complex regulates anterograde ER-derived vesicle trafficking in cortical neurites","author":"Koh","year":"2021","journal-title":"BioRxiv"},{"key":"10.1016\/j.conb.2021.08.003_bib28","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.bbrc.2017.05.002","article-title":"Identification of CLN6 as a molecular entity of endoplasmic reticulum-driven anti-aggregate activity","volume":"487","author":"Yamashita","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.conb.2021.08.003_bib29","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/jnc.15285","article-title":"An altered secretome is an early marker of the pathogenesis of CLN6 Batten disease","volume":"157","author":"Best","year":"2020","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.conb.2021.08.003_bib30","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ymgme.2018.09.009","article-title":"A\u00a0newly generated neuronal cell model of CLN7 disease reveals aberrant lysosome motility and impaired cell survival","volume":"126","author":"von Kleist","year":"2019","journal-title":"Mol Genet Metabol"},{"key":"10.1016\/j.conb.2021.08.003_bib31","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1093\/hmg\/ddy076","article-title":"Loss of CLN7 results in depletion of soluble lysosomal proteins and impaired mTOR reactivation","volume":"27","author":"Danyukova","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.conb.2021.08.003_bib32","doi-asserted-by":"crossref","first-page":"15592","DOI":"10.1038\/s41598-019-51588-w","article-title":"The neuronal ceroid lipofuscinosis protein Cln7 functions in the postsynaptic cell to regulate synapse development","volume":"9","author":"Connolly","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.conb.2021.08.003_bib33","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.bbadis.2018.11.011","article-title":"Neuronal ceroid lipofuscinosis related ER membrane protein CLN8 regulates PP2A activity and ceramide levels","volume":"1865","author":"Adhikari","year":"2019","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"key":"10.1016\/j.conb.2021.08.003_bib34","doi-asserted-by":"crossref","first-page":"581805","DOI":"10.3389\/fcell.2021.581805","article-title":"Cathepsin D variants associated with neurodegenerative diseases show dysregulated functionality and modified \u03b1-synuclein degradation properties","volume":"9","author":"Bunk","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.conb.2021.08.003_bib35","doi-asserted-by":"crossref","first-page":"15277","DOI":"10.1038\/ncomms15277","article-title":"Impaired prosaposin lysosomal trafficking in frontotemporal lobar degeneration due to progranulin mutations","volume":"8","author":"Zhou","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.conb.2021.08.003_bib36","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/ana.25351","article-title":"KCTD7 deficiency defines a distinct neurodegenerative disorder with a conserved autophagy-lysosome defect","volume":"84","author":"Metz","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.conb.2021.08.003_bib37","doi-asserted-by":"crossref","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","article-title":"An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex","volume":"34","author":"Zhang","year":"2014","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.conb.2021.08.003_bib38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40478-017-0476-y","article-title":"Glial cells are functionally impaired in juvenile neuronal ceroid lipofuscinosis and detrimental to neurons","volume":"5","author":"Parviainen","year":"2017","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.conb.2021.08.003_bib39","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/jnc.14545","article-title":"Astrocytes in juvenile neuronal ceroid lipofuscinosis (CLN3) display metabolic and calcium signaling abnormalities","volume":"148","author":"Bosch","year":"2019","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.conb.2021.08.003_bib40","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022261118","article-title":"GFAP hyperpalmitoylation exacerbates astrogliosis and neurodegenerative pathology in PPT1-deficient mice","volume":"118","author":"Yuan","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.conb.2021.08.003_bib41","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40478-018-0575-4","article-title":"Compromised astrocyte function and survival negatively impact neurons in infantile neuronal ceroid lipofuscinosis","volume":"6","author":"Lange","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.conb.2021.08.003_bib42","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/jnc.12385","article-title":"Microglia in juvenile neuronal ceroid lipofuscinosis are primed toward a pro-inflammatory phenotype","volume":"127","author":"Xiong","year":"2013","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.conb.2021.08.003_bib43","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.nbd.2017.06.012","article-title":"Conditional loss of progranulin in neurons is not sufficient to cause neuronal ceroid lipofuscinosis-like neuropathology in mice","volume":"106","author":"Petkau","year":"2017","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.conb.2021.08.003_bib44","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12974-017-1000-9","article-title":"Selective depletion of microglial progranulin in mice is not sufficient to cause neuronal ceroid lipofuscinosis or neuroinflammation","volume":"14","author":"Petkau","year":"2017","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.conb.2021.08.003_bib45","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.autneu.2018.07.003","article-title":"Paroxysmal sympathetic hyperactivity in Juvenile neuronal ceroid lipofuscinosis (Batten disease)","volume":"214","author":"Ostergaard","year":"2018","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.conb.2021.08.003_bib46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/gt.2017.4","article-title":"Extraneuronal pathology in a canine model of CLN2 neuronal ceroid lipofuscinosis after intracerebroventricular gene therapy that delays neurological disease progression","volume":"24","author":"Katz","year":"2017","journal-title":"Gene Ther"},{"key":"10.1016\/j.conb.2021.08.003_bib47","doi-asserted-by":"crossref","first-page":"165643","DOI":"10.1016\/j.bbadis.2019.165643","article-title":"Cardiac pathology in neuronal ceroid lipofuscinoses (NCL): more than a mere co-morbidity","volume":"1866","author":"Rietdorf","year":"2020","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"key":"10.1016\/j.conb.2021.08.003_bib48","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1177\/0883073820977997","article-title":"Cerliponase alfa for the treatment of atypical phenotypes of CLN2 disease: a retrospective case series","volume":"36","author":"Wibbeler","year":"2021","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.conb.2021.08.003_bib49","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1056\/NEJMoa1712649","article-title":"Study of intraventricular cerliponase alfa for CLN2 disease","volume":"378","author":"Schulz","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.conb.2021.08.003_bib50","doi-asserted-by":"crossref","first-page":"E5920","DOI":"10.1073\/pnas.1701832114","article-title":"Synergistic effects of treating the spinal cord and brain in CLN1 disease","volume":"114","author":"Shyng","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.conb.2021.08.003_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/S1525-0016(16)33171-9","article-title":"Translatable gene therapy for infantile neuronal lipofuscinosis","volume":"24","author":"Rozenberg","year":"2016","journal-title":"Mol Ther"},{"key":"10.1016\/j.conb.2021.08.003_bib52","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1016\/j.ymgme.2017.12.338","article-title":"Combination dosing of CLN1 gene therapy extends lifespan in a mouse model of infantile neuronal ceroid lipofuscinosis","volume":"123","author":"Rozenberg","year":"2018","journal-title":"Mol Genet Metabol"},{"key":"10.1016\/j.conb.2021.08.003_bib53","doi-asserted-by":"crossref","first-page":"313ra180","DOI":"10.1126\/scitranslmed.aac6191","article-title":"AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease","volume":"7","author":"Katz","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.conb.2021.08.003_bib54","doi-asserted-by":"crossref","first-page":"9669","DOI":"10.1523\/JNEUROSCI.1635-16.2016","article-title":"Self-complementary AAV9 gene delivery partially corrects pathology associated with juvenile neuronal ceroid lipofuscinosis (CLN3)","volume":"36","author":"Bosch","year":"2016","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.conb.2021.08.003_bib55","series-title":"15th annual WORLD symposium","article-title":"Gene therapy rescues pathological deficits, improves behavioral aspects, and prolongs survival in CLN3-, CLN6-, and CLN8- Batten Disease","author":"Cain","year":"2019"},{"key":"10.1016\/j.conb.2021.08.003_bib56","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/j.ymthe.2018.07.015","article-title":"Longitudinal in\u00a0vivo monitoring of the CNS demonstrates the efficacy of gene therapy in a sheep model of CLN5 batten disease","volume":"26","author":"Mitchell","year":"2018","journal-title":"Mol Ther"},{"key":"10.1016\/j.conb.2021.08.003_bib57","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.ymthe.2019.06.015","article-title":"Gene therapy corrects brain and behavioral pathologies in CLN6-batten disease","volume":"27","author":"Cain","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.conb.2021.08.003_bib58","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1093\/hmg\/ddz210","article-title":"Neonatal brain-directed gene therapy rescues a mouse model of neurodegenerative CLN6 Batten disease","volume":"28","author":"Kleine Holthaus","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.conb.2021.08.003_bib59","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.ymgme.2020.12.037","article-title":"Preclinical results in rodents strongly support clinical evaluation of scAAV9\/MFSD8 as a potential gene therapy for CLN7 patients","volume":"132","author":"Chen","year":"2020","journal-title":"Mol Genet Metabol"},{"key":"10.1016\/j.conb.2021.08.003_bib60","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ymthe.2020.09.033","article-title":"AAV9 gene therapy increases lifespan and treats pathological and behavioral abnormalities in a mouse model of CLN8-batten disease","volume":"29","author":"Johnson","year":"2021","journal-title":"Mol Ther"},{"key":"10.1016\/j.conb.2021.08.003_bib61","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb5413","article-title":"Slowing late infantile Batten disease by direct brain parenchymal administration of a rh.10 adeno-associated virus expressing CLN2","volume":"12","author":"Sondhi","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.conb.2021.08.003_bib62","series-title":"18th annual WORLD symposium","article-title":"An open-label, phase 1\/2a, AAV9-CLN3 gene transfer clinical trial for juvenile neuronal ceroid lipofuscinosis","author":"De los Reyes","year":"2021"},{"key":"10.1016\/j.conb.2021.08.003_bib63","series-title":"17th annual WORLD symposium","article-title":"Single-dose AAV9-CLN6 gene transfer slows the decline in motor and language function in variant late infantile neuronal ceroid lipofuscinosis 6: interim results from a phase 1\/2 trial","author":"De los Reyes","year":"2021"},{"key":"10.1016\/j.conb.2021.08.003_bib64","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ymthe.2018.11.013","article-title":"AAV-mediated progranulin delivery to a mouse model of progranulin deficiency causes T cell-mediated toxicity","volume":"27","author":"Amado","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.conb.2021.08.003_bib65","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41582-019-0138-8","article-title":"Therapeutic landscape for Batten disease: current treatments and future prospects","volume":"15","author":"Johnson","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.conb.2021.08.003_bib66","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1089\/hum.2016.190","article-title":"Gene therapy of adult neuronal ceroid lipofuscinoses with CRISPR\/Cas9 in zebrafish","volume":"28","author":"Yao","year":"2017","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.conb.2021.08.003_bib67","series-title":"American college of medical genetics and genomics (ACMG) annual meeting","article-title":"Hematopoietic stem cell gene therapy for lysosomal storage diseases","author":"Biffi","year":"2021"},{"key":"10.1016\/j.conb.2021.08.003_bib68","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/hmg\/ddu428","article-title":"The novel Cln1R151X mouse model of infantile neuronal ceroid lipofuscinosis (INCL) for testing nonsense suppression therapy","volume":"24","author":"Miller","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.conb.2021.08.003_bib69","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/jcmm.12744","article-title":"Tissue-specific variation in nonsense mutant transcript level and drug-induced read-through efficiency in the Cln1(R151X) mouse model of INCL","volume":"20","author":"Thada","year":"2016","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.conb.2021.08.003_bib70","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/s41591-020-0986-1","article-title":"Therapeutic efficacy of antisense oligonucleotides in mouse models of CLN3 Batten disease","volume":"26","author":"Centa","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.conb.2021.08.003_bib71","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1056\/NEJMoa1813279","article-title":"Patient-customized oligonucleotide therapy for a rare genetic disease","volume":"381","author":"Kim","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.conb.2021.08.003_bib72","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s12974-020-01996-x","article-title":"Sex- and region-biased depletion of microglia\/macrophages attenuates CLN1 disease in mice","volume":"17","author":"Berve","year":"2020","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.conb.2021.08.003_bib73","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.ymthe.2017.04.021","article-title":"Fingolimod and teriflunomide attenuate neurodegeneration in mouse models of neuronal ceroid lipofuscinosis","volume":"25","author":"Groh","year":"2017","journal-title":"Mol Ther"},{"key":"10.1016\/j.conb.2021.08.003_bib74","first-page":"117","article-title":"Short-term administration of mycophenolate is well-tolerated in CLN3 disease (juvenile neuronal ceroid lipofuscinosis)","volume":"43","author":"Augustine","year":"2018","journal-title":"JIMD Rep"},{"key":"10.1016\/j.conb.2021.08.003_bib75","doi-asserted-by":"crossref","first-page":"14338","DOI":"10.1038\/ncomms14338","article-title":"mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases","volume":"8","author":"Palmieri","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.conb.2021.08.003_bib76","doi-asserted-by":"crossref","first-page":"10309","DOI":"10.1074\/jbc.M114.610659","article-title":"Activation of peroxisome proliferator-activated receptor alpha induces lysosomal biogenesis in brain cells: implications for lysosomal storage disorders","volume":"290","author":"Ghosh","year":"2015","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.conb.2021.08.003_bib77","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s40263-019-00620-8","article-title":"Current and emerging treatment strategies for neuronal ceroid lipofuscinoses","volume":"33","author":"Kohlsch\u00fctter","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.conb.2021.08.003_bib78","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2353\/ajpath.2010.091267","article-title":"CNS-expressed cathepsin D prevents lymphopenia in a murine model of congenital neuronal ceroid lipofuscinosis","volume":"177","author":"Shevtsova","year":"2010","journal-title":"Am J Pathol"}],"container-title":["Current Opinion in Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959438821000945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959438821000945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:01:26Z","timestamp":1760706086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959438821000945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":78,"alternative-id":["S0959438821000945"],"URL":"https:\/\/doi.org\/10.1016\/j.conb.2021.08.003","relation":{},"ISSN":["0959-4388"],"issn-type":[{"type":"print","value":"0959-4388"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"On the cusp of cures: Breakthroughs in Batten disease research","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Neurobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conb.2021.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}